These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11462105)

  • 1. Oxidative damage to nuclear DNA: amelioration by melatonin. NEL Review.
    Reiter RJ
    Neuro Endocrinol Lett; 1999; 20(3-4):145-150. PubMed ID: 11462105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of oxygen toxicity by melatonin.
    Reiter RJ; Tan DX; Qi WB
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
    Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
    Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the evidence supporting melatonin's role as an antioxidant.
    Reiter RJ; Melchiorri D; Sewerynek E; Poeggeler B; Barlow-Walden L; Chuang J; Ortiz GG; Acuña-Castroviejo D
    J Pineal Res; 1995 Jan; 18(1):1-11. PubMed ID: 7776173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
    Reiter RJ; Tan DX; Manchester LC; Qi W
    Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin as a radioprotective agent: a review.
    Vijayalaxmi ; Reiter RJ; Tan DX; Herman TS; Thomas CR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):639-53. PubMed ID: 15183467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological actions of melatonin in oxygen radical pathophysiology.
    Reiter R; Tang L; Garcia JJ; Muñoz-Hoyos A
    Life Sci; 1997; 60(25):2255-71. PubMed ID: 9194681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
    Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD
    Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review.
    Reiter RJ
    Braz J Med Biol Res; 1993 Nov; 26(11):1141-55. PubMed ID: 8136717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ; Tan DX; Allegra M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging and oxygen toxicity: Relation to changes in melatonin.
    Reiter RJ
    Age (Omaha); 1997 Oct; 20(4):201-13. PubMed ID: 23604322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.
    Reiter RJ; Guerrero JM; Garcia JJ; Acuña-Castroviejo D
    Ann N Y Acad Sci; 1998 Nov; 854():410-24. PubMed ID: 9928448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of melatonin.
    Reiter RJ; Korkmaz A
    Saudi Med J; 2008 Nov; 29(11):1537-47. PubMed ID: 18997997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical implications of melatonin: receptor-mediated and receptor-independent actions.
    Reiter RJ; Tan DX; Manchester LC; Pilar Terron M; Flores LJ; Koppisepi S
    Adv Med Sci; 2007; 52():11-28. PubMed ID: 18217386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury.
    El-Missiry MA; Fayed TA; El-Sawy MR; El-Sayed AA
    Ecotoxicol Environ Saf; 2007 Feb; 66(2):278-86. PubMed ID: 16793135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin in relation to the "strong" and "weak" versions of the free radical theory of aging.
    Reiter RJ; Paredes SD; Korkmaz A; Manchester LC; Tan DX
    Adv Med Sci; 2008; 53(2):119-29. PubMed ID: 18930877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal deterioration caused by carcinogens as a consequence of free radical mediated tissue damage: a review of the protective action of melatonin.
    Gultekin F; Hicyilmaz H
    Arch Toxicol; 2007 Oct; 81(10):675-81. PubMed ID: 17823789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.